Open access · OA
via OpenAlex
TARGETING AGEING IN ASIA
Brian Keith Kennedy, Yap Seng Chong
Innovation in Aging · 2018
Abstract
The past three decades have seen the identification of a range of interventions that extend lifespan and Healthspan(definition) in animal models. A critical next step is to validate these interventions in humans, demonstrating that ageing is indeed malleable. Several drugs and supplements, including metformin, mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), acarbose and nicotinamide riboside have been identified as candidates and acarbose is of particular interest given its wider use as a diabetes drug in Asia. The NIA intervention testing program demonstrated that acarbose conferred robust lifespan extension specifically in males. A key next step is to determine whether the drug can affect a range of emergent biomarkers of human aging, providing evidence that it might alter human Healthspan. Strategies and progress toward intervention testing by the Centre for Healthy Ageing at National University of Singapore will be discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/geroni/igy023.2010
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Kennedy, B.K., & Chong, Y.S. (2018). TARGETING AGEING IN ASIA. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igy023.2010
Vancouver
Kennedy BK, Chong YS. TARGETING AGEING IN ASIA. Innovation in Aging. 2018. doi:10.1093/geroni/igy023.2010.
BibTeX
@article{brian2018TARGET,
title = {TARGETING AGEING IN ASIA},
author = {Brian Keith Kennedy and Yap Seng Chong},
journal = {Innovation in Aging},
year = {2018},
doi = {10.1093/geroni/igy023.2010},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pathobiology of Aging & Age-related Diseases 2019
Open access · CC-BY
Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset
The Journals of Gerontology Series A 2023
Open access · CC0
Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop
Journal of clinical medicine 2026
Open access · OA
Accelerated Vascular Aging in Women with Prior Preeclampsia: A Review of Epidemiology, Pathophysiological Mechanisms, and Geroprotective Strategies
Frontiers in Aging 2024
Open access · CC-BY
Climbing the longevity pyramid: overview of evidence-driven healthcare prevention strategies for human longevity
Frontiers in aging 2024
Open access · OA
Climbing the longevity pyramid: overview of evidence-driven healthcare prevention strategies for human longevity.
The Lancet Diabetes & Endocrinology 2018
Preprint · CC-BY